Ofev®

nintedanib esylate

Treatment of patients with idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD) and, in some countries, other chronic fibrosing interstitial lung diseases with a progressive phenotype.

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

‎Idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD) and, in some countries, other chronic fibrosing interstitial lung diseases with a progressive phenotype 

Brand Names

Ofev®

Active ingredients

nintedanib esylate